The Potential Benefit of Xiao-Yao-San Treatment in Patients With Insomnia

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Treatment
Interventions
DRUG

Xiao-Yao-San

Patients who received Xiao-Yao-San 9 g/day (Kaiser Pharmaceutical Co. Ltd.) were selected for the Xiao-Yao-San group by traditional Chinese doctor with 8 years of experience.

OTHER

Weight loss class(WLC) group

Participants who attended the WLCs in our hospital and were willing to participate in our study were included in the WLC group (control group). Our WLCs consisted of 8 sessions of 2-hour dietary advice/exercise guidance and 1 session of weight-loss consultation in 3 months. The participants assessed their weights at the beginning, at 1.5 months, and after every class. They underwent pre-PSG tests in the beginning and post-PSG tests after 3 months of lectures.

Trial Locations (1)

708

Tainan Hospital, Ministry of Health and Welfare, Tainan City

All Listed Sponsors
lead

Yu-Ching HSU

OTHER

NCT06417515 - The Potential Benefit of Xiao-Yao-San Treatment in Patients With Insomnia | Biotech Hunter | Biotech Hunter